Rchr
J-GLOBAL ID：201901019631404543
Update date: Nov. 08, 2023
Matsumoto Masaru
マツモト マサル | Matsumoto Masaru
Research field (1)：
Bio-, chemical, and soft-matter physics
Research theme for competitive and other funds (1)：
- 2021 - 2024 ヒト正常細胞におけるEML4-ALKの生物学的役割の検討
Papers (55)：
-
Yuto Terashima, Masaru Matsumoto, Hiroki Iida, Sae Takashima, Aya Fukuizumi, Susumu Takeuchi, Akihiko Miyanaga, Yasuhiro Terasaki, Kazuo Kasahara, Masahiro Seike. Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC. JTO clinical and research reports. 2023. 4. 11. 100578-100578
-
Takehiro Tozuka, Rintaro Noro, Akihiko Miyanaga, Shinji Nakamichi, Susumu Takeuchi, Masaru Matsumoto, Kaoru Kubota, Kazuo Kasahara, Masahiro Seike. Osimertinib early dose reduction as a risk to brain metastasis control in EGFR-mutant non-small cell lung cancer. Cancer medicine. 2023. 12. 17. 17731-17739
-
芳賀 三四郎, 柏田 建, 恩田 直美, 加藤 泰裕, 高野 夏希, 福泉 彩, 武内 進, 松本 優, 宮永 晃彦, 笠原 寿郎, et al. 悪性胸膜中皮腫との鑑別に苦慮した悪性リンパ腫の1例. 肺癌. 2023. 63. 4. 332-332
-
Shinji Nakamichi, Kaoru Kubota, Fenfei Zou, Anna Hayashi, Natsuki Takano, Naomi Onda, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Masahiro Seike. Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study. International journal of clinical oncology. 2023. 28. 7. 872-879
-
山川 美早紀, 武内 進, 寺嶋 勇人, 柏田 建, 深澤 美樹, 松本 優, 林 俊行, 宮永 晃彦, 笠原 寿郎, 清家 正博. 限局型小細胞肺癌に合併したLambert-Eaton症候群対し,細胞傷害性抗癌薬と抗コリンエステラーゼ阻害薬で早期症状改善を得た1例. 日本内科学会関東地方会. 2023. 686回. 50-50
ｍore...
MISC (78)：
-
高嶋紗衣, 松本優, 福泉彩, 恩田直美, 中道真仁, 武内進, 宮永晃彦, 笠原寿郎, 寺崎泰弘, 清家正博. Retrospective study of association between TTF-1 expression and antitumor effects of platinum+pemetrexed and immune checkpoint inhibitor combination therapy for lung adenocarcinoma. 日本呼吸器学会誌(Web). 2023. 12
-
戸塚猛大, 野呂林太郎, 中道真仁, 武内進, 松本優, 宮永晃彦, 笠原寿郎, 清家正博. Combination chemotherapy and immunotherapy for non-squamous cell carcinoma patients over 70 years old. 日本呼吸器学会誌(Web). 2023. 12
-
磯博和, 宮永晃彦, 戸塚猛大, 村田亜香里, 佐藤陽三, 中道真仁, 武内進, 松本優, 齋藤好信, 笠原寿郎, et al. A retrospective study of the efficacy and safety for pleurodesis in patients with interstitial lung disease. 日本呼吸器学会誌(Web). 2023. 12
-
飯田博紀, 宮永晃彦, 高嶋紗衣, 寺嶋勇人, 福泉彩, 恩田直美, 松本優, 武内進, 笠原寿郎, 清家正博. A retrospective study of the efficacy and safety of nivolumab plus ipilimumab combination therapy for malignant pleural mesothelioma. 日本呼吸器学会誌(Web). 2023. 12
-
恩田直美, 中道真仁, 松本優, 宮永晃彦, 清家正博. Afatinib in combination with pemetrexed and carboplatin after refractory to first-line osimertinib treatment in NSCLC patients with EGFR mutation. 日本呼吸器学会誌(Web). 2023. 12
ｍore...
Work history (1)：
Return to Previous Page
